Patients with residual depressive symptoms who received online mindfulness-based cognitive therapy (MBCT) plus usual care demonstrated significant gains in depression and functional outcomes, compared with patients who received usual care only.
A single dose of psilocybin combined with psychotherapy produced significant improvements in emotional and existential distress in patients with cancer that lasted more than 4 years, according to a published study.
Knowing someone with emotional or mental health problems increased the likelihood that people who screened positive for depression sought out depression treatment for themselves, according to a study published online in Psychiatric Services.
AXS-05, an investigational modulated-delivery tablet combining dextromethorphan and bupropion, significantly improved symptoms of depression in patients with major depressive disorder (MDD) in a recent phase 3 trial, announced developer Axsome Therapeutics Inc.
A meta-analysis recently published in The Lancet Psychiatry found that using medicinal cannabinoids to treat mental health disorders cannot be justified, due to a lack of evidence of effectiveness and known risks of the substances.
SAN DIEGO—Psilocybin-assisted psychotherapy appears to have a beneficial and lasting effect on patient mood, but possible approval of the treatment remains some time away, a researcher said at Psych Congress 2019.